CIK 0001590560
- Large accelerated filer
uniQure N.V.
Sign in to watch- Ticker
- QURE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- Phone
- +1 339-970-7000
- Business address
- PAASHEUVELWEG 25A, AMSTERDAM, Netherlands, 1105 BP
- Former names
- uniQure B.V.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $192,950
- in 1 filing, $193K under 10b5-1 plans
Net −$192,950. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-11-04 | Kaye Jack Director | Exercise or conversion 10b5-1 | +17,810 | $14.08 | $251K | 38,249 |
| 2025-11-04 | Kaye Jack Director | Sale 10b5-1 | −17,810 | $30.33 | $540K | 20,439 |
| 2025-11-04 | Kaye Jack Director | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −10,000 | 0 | ||
| 2025-11-04 | Kaye Jack Director | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −11,000 | 0 | ||
| 2025-11-04 | Kaye Jack Director | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −17,810 | 0 | ||
| 2025-09-26 | KLEMT CHRISTIAN Chief Financial Officer | Exercise or conversion 10b5-1 | +15,000 | $5.37 | $81K | 232,730 |
| 2025-09-26 | KLEMT CHRISTIAN Chief Financial Officer | Sale 10b5-1 | −15,000 | $55.00 | $825K | 217,730 |
| 2025-09-26 | KLEMT CHRISTIAN Chief Financial Officer | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −15,000 | 0 | ||
| 2025-09-24 | Kapusta Matthew C CEO, Managing Director | Exercise or conversion 10b5-1 | +51,316 | $7.53 | $386K | 702,770 |
| 2025-09-24 | Kapusta Matthew C CEO, Managing Director | Exercise or conversion 10b5-1 | +175,000 | $6.22 | $1.1M | 877,770 |
| 2025-09-24 | Kapusta Matthew C CEO, Managing Director | Sale 10b5-1 | −51,316 | $39.59 | $2.0M | 826,454 |
| 2025-09-24 | Kapusta Matthew C CEO, Managing Director | Sale 10b5-1 | −60,000 | $40.04 | $2.4M | 766,454 |
| 2025-09-24 | Kapusta Matthew C CEO, Managing Director | Sale 10b5-1 | −49,978 | $40.68 | $2.0M | 716,476 |
| 2025-09-24 | Kapusta Matthew C CEO, Managing Director | Sale 10b5-1 | −5,022 | $41.69 | $209K | 711,454 |
| 2025-09-24 | Kapusta Matthew C CEO, Managing Director | Sale 10b5-1 | −60,000 | $45.10 | $2.7M | 651,454 |
| 2025-09-24 | Kapusta Matthew C CEO, Managing Director | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −51,316 | 0 | ||
| 2025-09-24 | Kapusta Matthew C CEO, Managing Director | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −175,000 | 0 | ||
| 2025-09-24 | KLEMT CHRISTIAN Chief Financial Officer | Exercise or conversion 10b5-1 | +3,000 | $13.03 | $39K | 220,730 |
| 2025-09-24 | KLEMT CHRISTIAN Chief Financial Officer | Sale 10b5-1 | −3,000 | $40.04 | $120K | 217,730 |
| 2025-09-24 | KLEMT CHRISTIAN Chief Financial Officer | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −3,000 | 0 |
Page 7 of 13 · 251 trades